Bahrt Kenneth 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 6, 2013
Insider Transaction Report
Form 4
Bahrt Kenneth
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock $.01 par value per share
2013-02-04$1.01/sh−7,300$7,373→ 193,450 total - Sale
Common Stock $.01 par value per share
2013-02-04$1.04/sh−21,700$22,568→ 171,750 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012.